Mindfulness app for anxiety in underserved groups fizzles out early
NCT ID NCT06242080
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone app that teaches mindfulness meditation to help Black and Latino adults with anxiety during the COVID-19 pandemic. About 400 participants were assigned to one of two mindfulness programs or a waitlist. The trial was terminated early, so we don't have complete results on whether the app reduced anxiety or improved heart health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mindfulness meditation delivered via a smartphone app
What this could lead to
If it had succeeded, this could have pointed toward a simple, scalable way to reduce anxiety in underserved communities.
What could go wrong
The trial was terminated early, so we don't have clear results. It was also a small, early-stage study focused on a specific group, so findings may not apply broadly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599-7160, United States